2015
DOI: 10.1164/rccm.201502-0387oc
|View full text |Cite
|
Sign up to set email alerts
|

Pulmonary Nontuberculous Mycobacterial Infection. A Multisystem, Multigenic Disease

Abstract: Patients with PNTM have more low-frequency, protein-affecting variants in immune, CFTR, cilia, and connective tissue genes than their unaffected family members and control subjects. We propose that PNTM infection is a multigenic disease in which combinations of variants across gene categories, plus environmental exposures, increase susceptibility to the infection.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

4
105
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
5
5

Relationship

2
8

Authors

Journals

citations
Cited by 133 publications
(109 citation statements)
references
References 48 publications
4
105
0
Order By: Relevance
“…In a recent study of genetic variation in patients with respiratory infection with nontuberculous mycobacteria and bronchiectasis, along with some family members without these organisms, ORIGINAL RESEARCH researchers reported results that are congruent with our hypothesis that genetic variants in heritable connective tissue disorders contribute to the development of bronchiectasis (49). Specifically, these 87 individuals (with and without mycobacteria) were exome sequenced, and data were filtered to include only genetic variants that had a population frequency less than 2% and the ability to affect protein structure.…”
Section: Discussionsupporting
confidence: 62%
“…In a recent study of genetic variation in patients with respiratory infection with nontuberculous mycobacteria and bronchiectasis, along with some family members without these organisms, ORIGINAL RESEARCH researchers reported results that are congruent with our hypothesis that genetic variants in heritable connective tissue disorders contribute to the development of bronchiectasis (49). Specifically, these 87 individuals (with and without mycobacteria) were exome sequenced, and data were filtered to include only genetic variants that had a population frequency less than 2% and the ability to affect protein structure.…”
Section: Discussionsupporting
confidence: 62%
“…They propose that MAC isolates should be speciated to better predict clinical disease and outcomes. In addition to differences observed in pulmonary disease based on pathogen characteristics, host factors affecting disease were also identified and reported by Szymanski and colleagues (26). They assessed genetic variations in individuals with NTM lung disease compared with healthy family members and a nonrelated control group, specifically looking at variants in the immune, cystic fibrosis transmembrane conductance regulator, cilia, and connective tissue gene sets.…”
Section: Nontuberculous Mycobacterial Lung Diseasementioning
confidence: 97%
“…For NTM disease, a composite score would likely incorporate microbiological, chest imaging, and health-related quality-of-life measures. There is evidence that patients with pulmonary NTM have impaired mucociliary function and more lowfrequency variants in genes associated with immune, cystic fibrosis transmembrane conductance regulator, cilia, and connective tissue gene sets (28,29). In addition, there may be immunological markers that distinguish disease from airway colonization.…”
Section: Clinical Outcomes and Prognosis Develop A Composite Measure mentioning
confidence: 99%